InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (15 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
15
T+90 hit rate
100%
T+90 mean return
+60.4%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Peetz Christopher, Chairman & CEO. Officer active across 4 companies, notably Mirum Pharmaceuticals, Inc.. In total, 41 disclosures have been logged. Split: 2 buys · 15 sells. Total volume traded: €6m. Activity tracked since 10 May 2021. The latest transaction was filed on 10 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Peetz Christopher
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations41 total
20,000 shares@ US$2.9360.0010% mcap0.7% of flowCommon StockSEC:0001614740-26-000012:0
11,683 shares@ US$98.510.019% mcap14.7% of flowCommon StockSEC:0001614740-26-000012:1
6,017 shares@ US$99.250.0097% mcap7.6% of flowCommon StockSEC:0001614740-26-000012:2
2,300 shares@ US$100.140.0037% mcap2.9% of flowCommon StockSEC:0001614740-26-000012:3
4,315 shares0Common StockSEC:0001628280-26-048655:0
20,000 shares@ US$2.9360.0007% mcap1.3% of flowCommon StockSEC:0001614740-26-000011:0
12,134 shares@ US$121.650.019% mcap33.0% of flowCommon StockSEC:0001614740-26-000011:1
4,181 shares@ US$122.340.0065% mcap11.4% of flowCommon StockSEC:0001614740-26-000011:2
1,975 shares@ US$123.740.0031% mcap5.5% of flowCommon StockSEC:0001614740-26-000011:3
1,710 shares@ US$124.790.0027% mcap4.8% of flowCommon StockSEC:0001614740-26-000011:4
25,000 sharesCommon StockSEC:0001614740-26-000009:0
9,108 shares@ US$103.303515.5% of flowCommon StockSEC:0001614740-26-000007:0
12,500 sharesCommon StockSEC:0001614740-26-000003:0
12,797 sharesCommon StockSEC:0001614740-26-000002:0
21,070 shares0Common StockSEC:0001614740-26-000001:0
19,133 shares@ US$19.247.3% of flowCommon StockSEC:0001614740-25-000005:0
40,000 shares@ US$2.9362.5% of flowCommon StockSEC:0001415889-25-021521:0
40,000 shares@ US$2.9362.5% of flowCommon StockSEC:0001415889-25-021350:0
50,000 sharesCommon StockSEC:0001415889-25-008556:0
40,000 shares@ US$2.9366.6% of flowCommon StockSEC:0001415889-25-006524:0
9,102 shares@ US$48.222524.9% of flowCommon StockSEC:0001415889-25-002981:0
12,500 sharesCommon StockSEC:0001415889-25-002134:0
7,489 shares@ US$42.815317.9% of flowCommon StockSEC:0001415889-25-001143:0
65 shares@ US$21.0460.1% of flowCommon StockSEC:0001415889-24-026868:0
34,013 shares@ US$2.9365.4% of flowCommon StockSEC:0001415889-24-020053:0
25 of 41 declarations
About Peetz Christopher
Peetz Christopher is Président-Directeur Général. He is associated with Mirum Pharmaceuticals, Inc. as CHIEF EXECUTIVE OFFICER, and with ALPINE IMMUNE SCIENCES, INC. and Alpine Immune Sciences, INC. as Director. Across 36 filings in total, the 36 sampled filings cover the period from 2021-05-12 to 2026-07-08, with buy amounts of EUR 106099 and sell amounts of EUR 4192861, and the most frequent transaction nature is Cession.
